Dataset on

Abel Kolawole Oyebamiji, Oluwatumininu Abosede Mutiu, Folake Ayobami Amao, Olubukola Monisola Oyawoye, Temitope A Oyedepo, Babatunde Benjamin Adeleke, Banjo Semire

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Data in brief, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Dataset on biochemical inhibiting activities of selected phytochemicals inData in brief · 2023
Article
Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years.Computational and mathematical methods in medicine · 2022
Review
Dataset on theoretical bio-evaluation of 1,2,4-thiadiazole-1,2,4-triazole analogues against epidermal growth factor receptor kinase down regulating human lung cancer.Data in brief · 2021
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abel Kolawole OyebamijiDepartment of Basic Sciences, Adeleke University, P.M.B. 250, Ede, Osun State, Nigeria.

Oluwatumininu Abosede MutiuDepartment of Chemical Sciences, Osun State University, Osogbo, Osun State, Nigeria.

Folake Ayobami AmaoDepartment of Mathematics, Faculty of Science, Adeleke University, P.M.B. 250, Ede, Osun State, Nigeria.

Olubukola Monisola OyawoyeDepartment of Microbiology, Laboratory of Molecular of Biology, Immunology and Bioinformatics, Adeleke University, P.M.B. 250, Ede, Osun State, Nigeria.

Temitope A OyedepoDepartment of Biochemistry, Adeleke University, P.M.B. 250, Ede, Osun State, Nigeria.

Babatunde Benjamin AdelekeDepartment of Chemistry, University of Ibadan, Ibadan, Oyo State, Nigeria.

Banjo SemireComputational Chemistry Laboratory, Department of Pure and Applied Chemistry, Ladoke Akintola University of Technology, P.M.B. 4000, Ogbomoso, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, ten molecular compounds were optimised using density functional theory (DFT) method via Spartan 14. The obtained descriptors were used to develop quantitative structural activities relationship (QSAR) model using Gretl and Matlab software and the similarity between predicted IC

Indexed as

ADMETDFTDockingGlioblastomaInhibitorsIn-silicoQSARTriazole

Identifiers

PMID33457478

DOI10.1016/j.dib.2020.106703

PMCPMC7797363

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.